case_images: PMC6646467_01
case_images: Changes in white blood cell (WBC) count during the clinical course of DRESS.
case_images: fendo-10-00474-g0001.jpg
case_images: PMC6646467_01_fendo-10-00474-g0001.jpg
case_images: F1
case_images: Laboratory studies were remarkable for leukocytosis (26.82 x 109/L [reference range, 4-10 x 109/L]) (Figure 1) and eosinophilia (20.6% [reference range, 0-8%]) (Figure 2).
case_images: Changes in eosinophils (EOS) count during the clinical course of DRESS.
case_images: fendo-10-00474-g0002.jpg
case_images: PMC6646467_01_fendo-10-00474-g0002.jpg
case_images: F2
case_images: Laboratory studies were remarkable for leukocytosis (26.82 x 109/L [reference range, 4-10 x 109/L]) (Figure 1) and eosinophilia (20.6% [reference range, 0-8%]) (Figure 2).
case_images: Changes in alanine aminotransferase(ALT), aspartate aminotransferase(AST), and total bilirubin(TBIL) during the clinical course of DRESS.
case_images: fendo-10-00474-g0003.jpg
case_images: PMC6646467_01_fendo-10-00474-g0003.jpg
case_images: F3
case_images: The liver enzymes (Figure 3) were significantly elevated (aspartate transaminase 165 U/L [reference range, 9-50 U/L] and alanine aminotransferase 430 U/L [reference range, 15-40 U/L]).
case_images: Fluctuations of blood glucose before and after insulin therapy during the clinical course of DRESS.
case_images: fendo-10-00474-g0004.jpg
case_images: PMC6646467_01_fendo-10-00474-g0004.jpg
case_images: F4
case_images: Although the dose titration of insulin was rather tough, blood glucose levels gradually improved (Figure 4).